Leica Biosystems

With a rich history of innovation spanning over 150 years, we at Leica Biosystems are dedicated to one central mission: Advancing Cancer Diagnostics, Improving Lives. Our journey began in 1872, and since then, we have been at the forefront of pathology, tackling challenges head-on to empower medical professionals and provide patients with the answers they need. We are a global leader in workflow solutions, offering the most comprehensive portfolio in the industry, which covers every step from biopsy to diagnosis. This unique position allows us to break down the barriers between each stage of the pathology process, creating a more seamless and efficient path to a confident diagnosis.

We are proud to be a part of Danaher, a global science and technology innovator. This relationship provides us with unparalleled resources and expertise, enabling us to push the boundaries of what's possible in cancer diagnostics. Our team of over 3,000 passionate experts across the globe is the driving force behind our success. We are committed to a culture of continuous improvement and innovation, constantly striving to develop solutions that not only meet but anticipate the needs of our customers. From our advanced staining and digital pathology solutions to our comprehensive workflow management, every product we create is designed with the goal of improving diagnostic confidence and operational efficiency for laboratories worldwide. We envision a future where comprehensive insights enrich every cancer diagnosis, offering reassurance to all patients and their families. It is this vision that inspires us every day to continue our work in transforming the field of anatomic pathology.